180
Participants
Start Date
October 4, 2023
Primary Completion Date
October 31, 2026
Study Completion Date
October 31, 2026
C3NEF assay
This assay will consist of a dual test, detecting C3 convertase binding C3NEF autoantibodies and measuring the functional consequence by complement alternative pathway (AP) activity using two distinct ELISA designs: C3NEF detection assay and AP activity assay.
"Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Daccò", Ranica
Mario Negri Institute for Pharmacological Research
OTHER